The evidence-based guidelines for aggressive treatment of patients with high-risk non-ST-segment elevation acute coronary syndrome (NSTE ACS) who are troponin positive are being largely ignored.
Researchers say this finding, from an analysis of medical records of 5,039 patients treated at 149 hospitals, suggests these patients are not receiving optimum medical therapy.
The findings were presented here at the 2002 scientific sessions of the American College of Emergency Physicians (ACEP). A team led by Charles V. Pollack, Jr., MD, chairman of the department of emergency medicine at University of Pennsylvania, in Philadelphia, Pennsylvania, United States, stratified the patients on the basis of whether or not early troponin assay (within 24 hours of presentation) was positive or negative.
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!